Inborn Errors of Metabolism (IEM)

Similar documents
INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

Metabolic Disorders. Chapter Thomson - Wadsworth

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Suspected Metabolic Disease in the Newborn Period Acute Management "What do I do?" Barbara Marriage, PhD RD Abbott Nutrition

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Inborn Errors of Metabolism in the Emergency Department. Will Davies June 2014

The spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital

Medical Foods for Inborn Errors of Metabolism

Acute Management of Sick Infants with Suspected Inborn Errors of Metabolism

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

Work-Up and Initial Management of Common Metabolic Emergencies in the Inpatient Setting

Newborn Screening in Manitoba. Information for Health Care Providers

Inborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

3 HYDROXY 3 METHYLGLUTARYL CoA (3 HMG CoA) LYASE DEFICIENCY RECOMMENDATIONS ON EMERGENCY MANAGEMENT OF METABOLIC DISEASES

The laboratory investigation of lactic acidaemia. J Bonham/T Laing

Introduction to Organic Acidemias. Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.

Inborn Errors of Metabolism Clinical Approach to Diagnosis and Treatment

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD

Guideline for the diagnosis and management of isovaleryl-coa-dehydrogenase deficiency (isovaleric acidemia) - a systematic review -

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

HEREDITARY METABOLIC DISEASES

Positive Newborn Screens: What do you do next?

Newborn Screening: Focus on Treatment

ANATOMY OF A METABOLIC CRISIS: FAOD-style. Mark S. Korson, MD Tufts Medical Center Boston, MA

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

ESPEN Congress Madrid 2018

THE ED APPROACH OF THE CHILD WITH SUSPECTED METABOLIC DISEASE

ARGININOSUCCINIC ACIDEMIA (or ARGININOSUCCINATE LYASE DEFICIENCY) RECOMMENDATIONS ON EMERGENCY MANAGEMENT OF METABOLIC DISEASES

Clinical Management of Organic Acidemias and OAA Natural History Registry. Kim Chapman MD PhD Children s National Rare Disease Institute

e-learning Fatty Acid Oxidation Defects Camilla Reed and Dr Simon Olpin Sheffield Children s Hospital

Newborn Screening: Blood Spot Disorders

Urea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016

For Your Baby s Health Department of Health

Diagnosis of IEM. And Emergency Management

Metabolic diseases of the liver

Organic acidaemias (OAs) & Urea cycle disorders (UCDs) PRESENTATION & MANAGEMENT

TRANSAMINATION AND UREA CYCLE

UREA CYCLE DISORDERS - The What, Why, How and When

Training Syllabus CLINICAL SYLLABUS

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet

UK NATIONAL METABOLIC BIOCHEMISTRY NETWORK GUIDELINES FOR THE INVESTIGATION OF HYPERAMMONAEMIA

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN

Module : Clinical correlates of disorders of metabolism Block 3, Week 2

Isovaleric Acidemia: Quick reference guide

Lynne A. Wolfe, MS, ACNP, PNP, BC Department of Genetics Yale School of Medicine

Jana Novotná, Bruno Sopko. Department of the Medical Chemistry and Clinical Biochemistry The 2nd Faculty of Medicine, Charles Univ.

Metabolic Emergencies and the Pediatrician

Salicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes

بنام خدا هیپوگلیسمی درنوزادان و گاالکتوزمی دکتر انتظاری

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Neonatal Guidelines. Chapter 10: Metabolic V Date Revised : January 2017 Ratified 6 th February Date for Review: 1 st of March 2021

Providing the Right Fuels for FOD s. Elaina Jurecki, MS, RD Regional Metabolic Nutritionist Kaiser Permanente Medical Center Oakland, CA

Nutritional Management of Inborn Errors of Metabolism. Kay Davis, RD, CSP Esther Berenhaut, RD, CSP, CSR Aug 28, 2017

Carnitine palmitoyl transferase 2 deficiency (CPT2) is a rare inherited disorder that occurs when

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

Ornithine Transcarbamylase Deficiency (OTCD) Recommendations on Emergency Management of Metabolic Disease

Inborn Error Of Metabolism :

Testing Strategy for Inborn Errors of Metabolism in the Neonate Aditi I. Dagli, Roberto T. Zori and Bryce A. Heese. DOI: /neo.

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

TITLE: NURSING GUIDELINES FOR THE MANAGEMENT OF CHILDREN WITH METHYLMALONIC ACIDURIA. Eilish O Connell, Clinical Education Facilitator, NCIMD

National Metabolic Biochemistry Network Guidelines for the investigation of hypoglycaemia in infants and children

Very-long-chain acyl-coa dehydrogenase deficiency

How MS/MS Revolutionized Newborn Screening

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

Inborn Errors of Metabolism

Understanding metabolic disease

Fatty Acid Oxidation Disorders- an update. Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London

Inborn error of metabolism

Urea Cycle Disorders and Hyperammonemia: Diagnosable Treatable Screenable

Integrative Metabolism: Significance

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

Metabolic Precautions & ER Recommendations

Genomics & Modern Health Care Caring for the Special Children & Adults of Isolated Populations. Propionic Acidemia

BCM 225 LECTURE ON INBORN ERRORS OF METABOLISM OJEMEKELE O.

Newborn Screening in Washington State Saving lives with a simple blood spot

SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE

BIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona

My Experiences and Understanding of VLCAD Deficiency and its Treatment Charles R. Roe, MD June 26, 2011 (Now retired)

ACUTE & CHRONIC ETHANOL EFFECTS An Overview

A Guide for Prenatal Educators

Arizona Newborn Screening Program

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

Fatty acid oxidation. Naomi Rankin

Inborn errors of metabolism

NEONATAL HYPOGLYCEMIA HEATHER MCKNIGHT-MENCI, MSN, CRNP CHILDREN S HOSPITAL OF PHILADELPHIA

Fatty Acid Oxidation Disorders Organic Acid Disorders

Good Morning! OCTOBER 2, 2014

Glycogen Storage Disease

UPDATE ON UREA CYCLE DISORDERS TREATMENT

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

OVERVIEW M ET AB OL IS M OF FR EE FA TT Y AC ID S

Transcription:

Clinical Presentation Inborn Errors of Metabolism (IEM) Click on the following: - Clinical Pearl - link to movie clip - link to picture Investigations Blood Work Urine No Acidosis NH 4 + Metabolic Acidosis No NH 4 + Hypoglycemia General Treatment

Inborn Errors of Metabolism Individually rare, collectively common ~1 : 800-1500 Inherent deficiency in a key metabolic pathway: Carbohydrate vs. Fat vs. Protein Pathophysiology : Build up of toxic products cellular intoxication Cellular energy deprivation Combination of the above

Clinical Presentation Infant Looks like sepsis! Lethargy Hypotonia Decreased level of consciousness (LOC) Seizures Poor feeding Vomiting Sudden deterioration Children Mental retardation Regression Failure to thrive Coarse facial features Skeletal abnormalities Hernias Dietary aversion (protein/carbs) Deterioration after: New foods introduced Fasting

Blood Work Blood Work CBC+ Diff Blood Culture Blood gas Rationale/Predicted Result -Rule out sepsis -Pancytopenia (finding in some types of IEM) -Metabolic Acidosis -Alkalosis (seen initially in urea cycle defects from high NH 4 + ) Electrolytes + Ca/Mg/Phos Blood glucose Serum ketones NH + 4 (ammonia) Lactate AST, ALT, AlkPhos, GGT, -Signs of dehydration -Electrolyte derangements can have similar presentation -Hypoglycemia -Hydroxybutyrate: should be present if patient hypoglycemic - *** NO tourniquet, send on ice and process immediately *** NO tourniquet, send on ice and process immediately -Elevated liver enzymes bili, albumin, coags Acyl-carnitine profile, (Pyruvate) *** NO tourniquet, send on ice and process immediately -Pyruvate: only done if lactate high (only needed for pyruvate/ lactate ratio), need Biochemical/genetics lab approval + need special collection tubes. Plasma amino acids Newborn screen Must call to unlock the results

Newborn Screen (BC) 22 disorders tested in British Columbia Other provinces test for a spectrum Pertinent to IEM: Amino acid disorders PKU MSUD Citrullinemia Agininosuccinic Aciduria Homocystinuria **Tyrosinemia Type 1 - (not yet included but possibly added soon!) Fatty acid oxidation defects VLCAD LCHAD (Not LCAD- Long-chain 3-hydroxyacyl-CoA dehydrogenase) ****TFP (trifunctional protein deficiency) severe form of LCHAD MCAD Organic Acid Defects PROP (Propionic acidemia) MUT (Methylmalonic Acidemia) Cobalamin Disorders Glutaric Aciduria, Type I Isovaleric Acidemia Galactosemia Galactosemia

PKU - Cause: phenylalanine hydroxylase enzyme deficiency - Ddx: rare forms of BH 4 Cofactor deficiency - mousy odour - Light complexion - Eczema - Mental retardation and hyperactivity

MSUD - 1 st week of life - Smells sweet - Periods of hypertonicity - Secondary hypoglycemia - Ketosis

Tyrosinemia Type 1 - Smells of boiled cabbage

MCAD - Encephalopathy - Hypoglycemia

Isovaleric Acidemia - Smells like sweaty feet

Glutaric Aciduria, Type 1 Subdural bleeds Needs to be included in the non-accidental injury work up

Galactosemia Mechanism: Deficiency of galactose-1-phosphate uridyl transferase Leads to galactose-1-phosphate Clinical presentation: Presents @ ~end of 1 st, start of 2 nd week of life Recurrent Escherichia coli sepsis Galactose-1-phosphate is toxic to the liver: **Jaundice Vomiting Diarrhea Poor weight gain Cataracts Investigations: Urine for reducing substances: looking for non-glucose reducing substances Treatment: Stop galactose containing feeds Only time an infant needs SOY formula Only ISOMIL will work!

Homocystinuria ***Increased risk of stroke Clinical Presentation: Marfanoid appearance Dislocated lens etc. Mental retardation Treatment: pyridoxine

Urine Urine Tests Urinalysis Rationale/Predicted Result - Rule out sepsis - Ketones - In infants, should only be present if hypoglycemic! Urine Culture - Rule out sepsis Urine organic acids Urine reducing substances -Useful in galactosemia (non-glucose reducing substances), fructose intolerance, tyrosinemia

General Treatment Treatment STOP protein intake Rationale -Urea cycle defects/organic acid/amino acid defect -Prophree formula (has no protein) IV glucose (D10@ infusion rate of 8-10 mmol/kg/min) - Treats hypoglycemia - Provides calories to prevent protein catabolism - May need insulin to control glucose levels **may add IV lipids if no signs of fatty acid oxidation defect IV arginine (6ml/kg 10% arginine HCl over 90 min) IV sodium benzoate -Essential amino acid -Helps to excrete the excess nitrogen waste products in Argininosuccinic Aciduria and Citrullinemia -Increases excretion of ammonia by activating alternate pathways IV phenylacetate IV carnitine -Fatty acid oxidation defects: treats possible carnitine deficiency -Organic acidurias: binds toxic organic acids for excretion in urine Cofactors/vitamin Specific treatments Hemodialysis -Organic acidemia: hydroxycobalamin, biotin -Please see individual disorders for specific treatments -Arrange with ICU/Neprhology -Recall reasons for dialysis (AEIOU) -Acid/Base disorders, Electrolyte disorders (including Ammonia!), Intoxication, Overload, Uremic encephalopathy

NH 4 + Presentation <24 hours old ph N - (possible 1 o respiratory alkalosis) Normal lactate NH + 4 Acidosis Anion gap ± Lactate ±Ketosis Hypoglycemia No Ketosis LFTs NH + 4 ± Hypoglycemia NH 4 + Transient Hyperammonemia of the Newborn Urea Cycle Defect Organic Acidemia Fatty Acid Oxidation Defect (Most likely )

Transient Hyperammonemia Clinical Presentation: Extremely sick of the Newborn Usually large premature neonate (~36wks) Symptomatic pulmonary disease (respiratory distress) Caused by compensatory respiratory alkalosis Does not recur! Treatment: Follow treatment for NH 4 +

Urea Cycle Defect Ornithine Transcarbamylase Deficiency The only X-linked urea cycle defect All other urea cycle defects are autosomal recessive

Fatty Acid Oxidation Defect Two mechanisms: Impaired capacity to use stored fat as fuel in periods of fasting with depleted glycogen stores Defect in carnitine which transports fatty acids during oxidation Recall Defects lead to a decrease in Acetyl CoA and therefore ketone production Thus presentation is most often a non ketotic hypoglycemia Screening: Urine Organic Acids Plasma acyl-carnitine profile Examples Treatment: IV glucose Carnitine supplementation (except in LCHAD where carnitine can lead to accumulation of toxins that cause severe arrhythmias and cardiomyopathy)

Examples VLCAD = Very Long Chain Acyl-CoA Dehydrogenase Deficiency LCHAD = Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency MCAD = Medium Chain Acyl-CoA Dehydrogenase Deficiency Clinical presentation: Non ketotic hypoglycemia Reye like reaction ALTE/Sudden death May have family history of SIDS Fat accumulation in liver or muscle

Organic Acidemia 4 key examples: Organic Acid Defect Treatment (cofactor/vitamin to residual enzyme activity) Methylmalonic Acidemia Hydroxocobalamin(B12) Proprionic Acidemia Multiple carboxylase PO/NG Biotin PO/NG Biotin Glutaric acidemia type 1 Riboflavin

Metabolic Acidosis Normal Anion Gap NOT IEM!!! Increased Anion Gap (MUDPILES) (No ketosis, Normal Lactate) - RTA - Diarrhea Acidosis Anion gap ± Lactate ±Ketosis ± Hypoglycemia NH + 4 Lactate Normal Glucose Organic Acidemia Mitochondrial Disorders

Organic Acidemia 4 key examples: Organic Acid Defect Treatment (cofactor/vitamin to residual enzyme activity) Methylmalonic Acidemia Hydroxocobalamin(B12) Proprionic Acidemia Multiple carboxylase PO/NG Biotin PO/NG Biotin Glutaric acidemia type 1 Riboflavin

(MUDPILES) anion gap In IEM, hidden anions are lactate or organic acids M Methanol U D P I L E S Uremia DKA Peraldehyde Isoniazid, Iron Lactate Ethylene Glycol Salicylates

No Acidosis No NH 4 + Non Ketotic Hyperglycinemia Homocystinuria

Non-Ketotic Hyperglycinemia Clinical Presentation Severe and progressive encephalopathy Uncontrolled hiccups and apnea Myoclonic seizures Hypotonia Investigations: No urine/serum ketones Increased glycine in blood and CSF

Homocystinuria ***Increased risk of stroke Clinical Presentation: Marfanoid appearance Dislocated lens etc. Mental retardation Treatment: pyridoxine

Hypoglycemia Acidosis ± Lactate Hypoglycemia Anion gap Hepatomegaly Liver Failure ±Ketosis ± Lactate LFTs ±Ketosis NH 4 + ± Hypoglycemia NH 4 + Organic Acidemia Glycogen Storage Disorder (GSD) **Note: some exceptions! Tyrosinemias GSD IV Galactosemia Neimann Pick Fatty Acid Oxidation Defects Hyperinsulinemia (Type C)

Organic Acidemia 4 key examples: Organic Acid Defect Treatment (cofactor/vitamin to residual enzyme activity) Methylmalonic Acidemia Hydroxocobalamin(B12) Proprionic Acidemia Multiple carboxylase PO/NG Biotin PO/NG Biotin Glutaric acidemia type 1 Riboflavin

Fatty Acid Oxidation Defect Two mechanisms: Impaired capacity to use stored fat as fuel in periods of fasting with depleted glycogen stores Defect in carnitine which transports fatty acids during oxidation Recall Defects lead to a decrease in Acetyl CoA and therefore ketone production Thus presentation is most often a non ketotic hypoglycemia Screening: Urine Organic Acids Plasma acyl-carnitine profile Examples Treatment: IV glucose Carnitine supplementation (except in LCHAD where carnitine can lead to accumulation of toxins that cause severe arrhythmias and cardiomyopathy)

Glycogen Storage Disorder (GSD) Mechanism: Unable to release glucose from glycogen Several types assigned #s based on order of discovery Liver types: Type 0, I, III, VI, IX Hypoglycemia is presenting symptom Muscle types: Type II (Pompe), V, VII Presents with rhabdomyolysis and weakness

Galactosemia Mechanism: Deficiency of galactose-1-phosphate uridyl transferase Leads to galactose-1-phosphate Clinical presentation: Presents @ ~end of 1 st, start of 2 nd week of life Recurrent Escherichia coli sepsis Galactose-1-phosphate is toxic to the liver: **Jaundice Vomiting Diarrhea Poor weight gain Cataracts Investigations: Urine for reducing substances: looking for non-glucose reducing substances Treatment: Stop galactose containing feeds Only time an infant needs SOY formula Only ISOMIL will work!